Philip Howard
PhD
Chief Scientific Officer
👥Biography 个人简介
Philip Howard is the inventor of pyrrolobenzodiazepine dimer ADC payloads and co founded Spirogen. His PBD technology is used in several clinical and approved ADCs including loncastuximab tesirine. He has published extensively on DNA binding agents and payload chemistry. His work expanded the range of payload classes available for antibody drug conjugates.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Philip Howard 的研究动态
Follow Philip Howard's research updates
留下邮箱，当我们发布与 Philip Howard（Spirogen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment